HLA-DR Expression on Leukemic Progenitor Cells before Allogeneic Hematopoietic Cell Transplantation Adds Prognostic Value in the Presence of MRD
Maximilian Alexander Röhnert(University Hospital Carl Gustav Carus), Carsten Müller‐Tidow(Heidelberg University), Michael Krämer(University Hospital Carl Gustav Carus), Uta Oelschlaegel(University Hospital Carl Gustav Carus), Christoph Röllig(University Hospital Carl Gustav Carus), Ingmar Glauche(Institut für Medizinische Informatik, Biometrie und Epidemiologie), Jonas Schadt(University Hospital Carl Gustav Carus), Claudia D. Baldus(University Hospital Schleswig-Holstein), Jan Moritz Middeke(Fresenius (Germany)), Martin Bornhaeuser(German Cancer Research Center), Friedrich Stölzel(German Cancer Research Center), Desireé Kunadt(University Hospital Carl Gustav Carus), Uwe Platzbecker(National Center for Tumor Diseases), Friedemann Uschner(Institut für Medizinische Informatik, Biometrie und Epidemiologie), Hubert Serve(Goethe University Frankfurt), Lars Thielecke(Institut für Medizinische Informatik, Biometrie und Epidemiologie), Johannes Schetelig(University Hospital Carl Gustav Carus), Malte von Bonin(Städtisches Klinikum Dresden), Christian Thiede(University Hospital Carl Gustav Carus)
Cited by 0
Related Papers
Diagnosis and management of AML in adults: 2022 recommendations from an international expert panel on behalf of the ELN
|Blood|2022|3.1k
Midostaurin plus Chemotherapy for Acute Myeloid Leukemia with a <i>FLT3</i> Mutation
|New England Journal of Medicine|2017|2.2k
Retinoic Acid and Arsenic Trioxide for Acute Promyelocytic Leukemia
|New England Journal of Medicine|2013|1.6k